Similar articles

• Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.

  Ikeda A, Nishimura K, Izumi T. Ikeda A, et al. Chest. 1996 Jan;109(1):294. doi: 10.1378/chest.109.1.294. Chest. 1996. PMID: 8549208 No abstract available.
• Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.

  Colice GL. Colice GL. Am J Med. 1996 Jan 29;100(1A):11S-18S. doi: 10.1016/s0002-9343(96)80037-4. Am J Med. 1996. PMID: 8610712 Clinical Trial.
• Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.

  Pillet O, Manier G, Castaing Y. Pillet O, et al. Monaldi Arch Chest Dis. 1998 Feb;53(1):3-8. Monaldi Arch Chest Dis. 1998. PMID: 9632900 Clinical Trial.
• Anticholinergic bronchodilators.

  Witek TJ Jr. Witek TJ Jr. Respir Care Clin N Am. 1999 Dec;5(4):521-36. Respir Care Clin N Am. 1999. PMID: 10565879 Review.
• Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.

  Jarvis B, Markham A. Jarvis B, et al. Drugs Aging. 2001;18(6):441-72. doi: 10.2165/00002512-200118060-00006. Drugs Aging. 2001. PMID: 11419918 Review.